Molecular basis of parthenolide-dependent proapoptotic activity in cancer cells

Folia Histochemica et Cytobiologica

Volumn 46, Issue 2, 2008, Pages 129-135

  Pajak, Beata ^a   Gajkowska, Barabara ^a   Orzechowski, Arkadiusz ^a,b  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Apoptosis; Cancer cells; Parthenolide

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PARTHENOLIDE; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BID; REACTIVE OXYGEN METABOLITE; STAT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; SESQUITERPENE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL; CANCER INHIBITION; CARCINOGENESIS; CELL DEATH; CONFORMATIONAL TRANSITION; DRUG ISOLATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC TRANSCRIPTION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PROTEIN CONFORMATION; REVIEW; SIGNAL TRANSDUCTION; TANACETUM PARTHENIUM; ANIMAL; DRUG EFFECT; METABOLISM; NEOPLASM; PATHOLOGY;

TANACETUM PARTHENIUM;

ANIMALS; APOPTOSIS; HUMANS; MITOCHONDRIA; NEOPLASMS; NF-KAPPA B; SESQUITERPENES; STAT TRANSCRIPTION FACTORS;

EID: 48449083208     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-008-0019-2     Document Type: Review

References (69)

1. Hahne M, Rimoldi D, Schroter M, Romero P, Schreier M, French LE, Schneider P, Bornand T, Fontana A, Lienard D, Cerottini J, Tschopp J. Melanoma cells expression of Fas(Apo-1/CD 95) ligand: implications for tumor immune escape. Science. 1996;274:1363-1366.
2. Medema JP, de Jong J, van Hall T, Melief CJ, Offringa R. Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein. J Exp Med. 1999;190:1033-4038.
3. Igney FH, Krammer PH. Immune escape of twnors: apoptosis resistance and counterattack. J Leukoc Biol 2002;71:907-920.
4. Johnson ES, Kadam NP, Hylands DM, Hylands PJ. Efficacy of feverfew as prophylactic treatment for migraine. Br Med J. 1985,31:569-573.
5. Biggs MJ, Johnson ES, Persaud NP, Rateliffe DM. Platelet aggregation in patients using feverfew for migraine. Lancet. 1982,2:776.
6. Hall ICH, Lee KH, Starnes CO, Sumida Y, Wu RY, Waddell TG, Cochran JW, Gerhart KG. Anti-inflammatory activity of sesquiterpene lactones and related compounds. J Pharm Sci. 1979,68:537-542.
7. Jain NK, Kulkarni SK. Antinociceptive and anti-inflammatory effects of Tanacetum parthenium L. extracts in mice and rats. J Ethnopharm. 1999;68:251-259.
8. Knight DW. Feverfew, chemistry and biological activity. Nat Prod Rep. 1995;12:271-276.
9. Bork PM, Schmitz ML, Kuhnt M, Escher C, Heinrich M. Sesquiterpene lactone containing Mexican Indian medical plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF-κB. FEBS Lett. 1997,402:85-90.
10. Zhang S, Ong CN, Shen HM. Critical roles of intracellular thiols and calcium in parthenolide-induced apoptosis in human colorectal cancer cells. Cancer Lett. 2004;208:143-153.
11. Woynarowski JM, Konopa J. Inhibition of DNA biosynthesis in HeLa cells by cytotoxic and antitumor sesquiterpene lactones. Mol Pharmacol. 1981;19:97-102.
12. Bours; V, Bentires-Alj M, Hellin AC, Viatour P, Robe P, Delhalle S, Benoit V, Merville MP. Nuclear factor- B, cancer and apoptosis. Biochem Pharmacol. 2000;60:1085-1090.
13. Shishodia S, Aggarwal BB. Nuclear factor-kappa activation: a question of fife or death. J Biochem Mol Biol. 2002;35:28-40.
14. Trubiani O, Salvolini E, Vignini A, D'Arcangelo C, Di Primo R, Mazzanti L. NF-kappaB and NOS may play a role in human RPMI-8402 cell apoptosis. Cell Biol Int. 2005;29:529-536.
15. Fan M, Ahmed KM, Coleman MC, Spitz DR, Li JJ. Nuclear factor-kappa B and manganese superoxide dismutase mediate adaptive radioresistance in low-dose irradiated mouse skin epithelial cells. Cancer Res. 2007;67:3220-3228.
16. Wang T, Zhang X, Li JJ. The role of NF-κB in the regulation of cell stress responses. Int Immunopharmacol. 2002;2: 1509-1520.
17. Munzert G, Kirchner D, Stobbe H, Bergman L, Schmid RM, Dolmer H, Heimpel H. Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-kappaB/Rel-regulated inhibitors of apoptosis. Blood 2002;100:3749-3756.
18. Storz P, Doppler H, Ferran C Grey ST, Toker A. Functional dichotomy of A20 in apoptotic and necrotic cell death. Biochem J. 2005,387:47-55.
19. Osawa Y, Nagaki M, Banno Y, Brenner DA, Nozawa Y, Moriwaki H, Nakashima S. Expression of the NF-kappaB target gene X-ray-inducible immediate early response factor 1 short enhances TNF-alpha-induced hepatocyte apoptosis by inhibiting Akt activation. J Immunol. 2003;170:4053-4060.
20. Khoshnan A, Tindell C, Laux I, Bae D, Bennett B, Nei AE. The NF-kappaB cascade is important in in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes. J Immunol. 2000;165: 1743-1754.
21. Gilmore TD, Temin HM. Different localization of the product of the v-rel oncogene in chicken fibroblasts and spleen cells correlates with transforming by REV-T. Cell. 1986;44:791-800.
22. Wieckowski E, Atarashi Y, Stanson J, Sato TA, Whiteside TL. FAP-1 mediated activation of NF-kappaB induces resistance of head and neck cancer to Fas-induced apoptosis. J Cell Biochem. 2007;100:16-28.
23. Montagut C, Tusquest I, Ferrer B, Corominas JM, Bllosillo B, Campas C, Suarez M, Fabregat X, Campo E, Gascon P, Serrano S, Fernandez PL, Rovira A, Albanell J. Activation of nuclear factor kappaB is linked to resistance to neoadjuvant chemotherapy in breast cancer patients. Endocr Relat Cancer. 2006;13:607-616.
24. Horie R, Watanabe T. The biological basis of Hodgin's lymphoma. Drug News Perspect. 2003;16:649-656.
25. Braeuer SJ, Bunker C, Mohr A, Zwacka RM. Constitutively activated nuclear factor-kappa B, but not induced NF-κB, leads to TRAIL resistance by up-regulation of X-linked inhibitor of apoptosis protein in human cancer cells. Mol Cancer Res. 2006;4:715-728.
26. Wu JT, Kral JG. The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy. J Surg Res. 2005; 123:158-169.
27. Ghosh, S, May MJ, Kopp EB. NF-κB and Re1 projoins: evolutionary conserved mediators of immune responses. Annu Rev Immunol. 1998;16:225.
28. Helmer SP, Hofmann TG, Droge W, Schmitz ML. The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-κB by targeting the IκB kinase complex. J Immunol. 1999; 163:5617-5623.
29. Malinin NL, Boldin MP, Kovalenko AV, Wallach D. MAP3K-related kinase involved in the NF-κB induction by TNF, CD95 and IL-1. Nature. 1997;385:540.
30. Lee FS, Peters RT, Dang LC, Maniatis T. MEKK1 activates both IκB kinase α and IκB kinase β. Proc Natl AcadSci USA. 1998;95:9319.
31. Kwok BH, Koh B, Ndubuisi MI, Elofsson M, Crews CM. The anti-inflammatory natural product parthenolide from the medical herb Feverfew directly binds to and inhibits IkappaB kinase. J Chem Biol. 2001;8:759-766.
32. Saadane A, Masters S, DiDonato J, Li J, Berger M. Parthenolide inhibits IkappaB kinase, NF-κB activation and inflammatory response in cystic fibrosis cells in mice. Am J Respir Cell Mol Biol. 2007,36:728-36.
33. Kim JH, Liu L, Lee SO, Kim YT, You KR, Kim DG. Susceptibility of cholangiocarcnoma cells to parthenolide-induced apoptosis. Cancer Res. 2005;65:6312-6320.
34. Sweeney CJ, Mehrotra S, Sadaria MR, Kumar S, Shortle NH, Roman Y, Sheridan C, Campbell RA, Murry DJ, Badve S, Nakshatri H. The sesquiterpene lactone parthenolide in combination with docetaxel reduces metastasis and improves survival in a xenograft model of breast cancer. Mol Cancer Ther 2005;4:1004-1012.
35. Zhang S, Lin ZN, Yang CF, Shi Y, Ong CN, Shen HM. Supressed NF-κB and sustained JNK activation contribute to the sensitization effect of parthenolide to TNF-α-induced apoptosis in human cancer cells. Carcinogenesis. 2004,25:1-9.
36. Oka D, Nishimura Y, Shiba M, Nakai Y, Arai Y, Nakayama M, Takayama H, Inoue H, Okayama A, Nonomura N. Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-kappaB. Int J Cancer. 2007,120:2576-2581.
37. Meyer T, Vinkemeier U. STAT nuclear translocation: potential for pharmacological intervention. Expert Opin Ther Targets. 2007;11:1355-1365.
38. Bromberg J. Stat proteins and oncogenesis. J Clin Invest. 2002;109:1139-1142.
39. Lee TK, Man K, Poon RT, Lo CM, Yuen AP, Ng IO, Ng KT, Leonard W, Fan ST. Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial-mesenchymal transition. Cancer Res. 2006;66:9948-9956.
40. Ma XT, Wang S, Ye YJ, Du RY, Cui ZR, Somsouk M. Constitutive activation of Stat3 signaling pathway in human colorectal carcinoma. World J Gastroenterol 2004;10:1569-1573.
41. Pedranzini L, Leitch A, Bromberg J. Stat3 is required for the development of skin cancer. J Clin Invest. 2004;114:619-622.
42. Sheen-Chen SM, huang CC, Tang RP, Yang CH, Chou FF, Eng HL. Signal transducer and activator of transcription 1 in breast cancer: analysis with tissue microarray. Anticancer Res. 2007;27:2481-2486.
43. Ferrajoli A, Faderl S, Ravandi F, Estrov Z. The JAK-STAT pathway: a therapeutic target in hematological malignancies. Curr Cancer Drug Targets. 2006;6:671-679.
44. Kanda N, Seno H, Konda Y, Marusawa H, Kanai M, Nakajima T, Kawashima T, Nanakin A, Sawabu T, Uenoyama Y, Sekikawa A, Kawada M, Suzuki K, Kayahara T, Fukui H, Sawada M, Chiba T. STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene. 2004;23:4921-4929.
45. Sobota R, Szwed M, Kasza A, Bugno M, Kordula T. Parthenolide inhibits activation of signal transducers and activators of transcription (STATs) induced by cytokines; of the IL-6 family. Biochem Biophys Res Commun. 2000;267:329-333.
46. Knowles BB, Howe CC, Aden DP. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science. 1980;209:497-499.
47. Schnyder B, Schnyder-Candrian S, Panski A, Bommel H, Heim M, Duschl A, Moser R. Phytochemical inhibition of interleukin-4 activated Stat6 and expression of VCAM-1. Biochem Biophys Res Commun. 2002; 292:841-847.
48. Legendre F, Dudhia J Pujol JP, Bogdanowicz P. JAK/STAT but not ERK1/ERK2 pathway mediates interleukm (IL)-6/soluble IL-6R down-regulation of type II collagen, aggrecan core and link protein transcription in articular chondrocytes. Association with a down-regulation of SOX9 expression. J Biol Chem. 2003; 278:2903-2912.
49. Chang J, Karin M. Mammalian MAP kinase signaling cascades. Nature. 2001,410:37-40.
50. Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA, Davia RJ. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science. 2000;288:870-874.
51. Chen W, Bowden GT. Role of p38 mitogen-activated protein kinases in ultraviolet-B irradiation-induced activator protein 1 activation in human keratinocytes. Mol Carcinog. 2000;28: 196-202.
52. Won YK, Ong CN, Shi Y, Shen HM. Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms. Carcinogenesis. 2004;25:1449-1458.
53. Tang G, Minemoto Y, Dibling B, Purcell NH, Li Z, Karin M, Lin A. Inhibition of JNK activation through NF-kappaB target genes. Nature. 2001;414:313-317.
54. Varfolomeev EE, Ashkenazi A. Tumor necrosis factor: an apoptosis JuNKie? Cell. 2004;116:491-497.
55. Shamnugam F, Jayaprakasan V, Gokmen-Polar Y, Kelich S, Miller KD, Yip-Schneider M, Cheng L, Bhat-Nakshatri P, Siedge GW, Nakshatri H, Zheng QH, Miller MA, DeGrado T, Hutchins GD, Sweeney CJ. Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model. Prostate. 2006;66: 1498-1511.
56. Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today. 1994;15:7-10.
57. Hampton MB, Orrenius S. Redox regulation of apoptotic cell death. Biofactors. 1998;8:1-5.
58. Ghibelli I, Coppola S, Rotilio G, Lafavia E, Maresca V, Ciriolo MR. Non-oxidative loss of glutathione in apoptosis via GSH extrusion. Biochem Biophys Res Commun. 1995;216: 313-320.
59. Wen J, You KR, Lee SY, Song CH, Kim DG. Oxidative stressmediated apoptosis. J Biol Chem. 2002;277:38954-38964.
60. Zhang S, Ong CN, Shen HM. Involvement of proapoptotic bcl-2 family members in parthenolide-induced mitochondrial dysfunction and apoptosis. Cancer Lett. 2004;211:175-188.
61. Li H, Zhu H, xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 1998;94:491-501.
62. Degenhardt K, Sundararajan R, Lindsten T, Thompson C, White E. Bax and Bak independently promote cytochrome c release from mitochondria. J Biol Chem. 2002;277:14127-14134.
63. Wang W, Adachi M, Kawamura R, Sakamoto H, Hayashi T, Ishida T, Imai K, Shinomura Y. Parthenolide-induced apoptosis in multiple myeloma cells involves reactive oxygen species generation and cell sensitivity depends on catalase activity. Apoptosis. 2006;11:2225-2235.
64. Zunino SJ, Ducore JM, Stroms DH. Parthenolide induces significant apoptosis and production of reactive oxygen species in high-risk pre-B leukemia cells. Cancer Lett. 2007;254:119-127.
65. Pajak B, Gajkowska B, Orzechowski A. Cycloheximide-mediated sensitization to TNF-α-induced apoptosis in human colorectal cancer cell line COLO 205; role of FLIP and metabolic inhibitors. J Physiol Pharmacol. 2005;56:101-118.
66. Suzuki A, Tsutomi Y, Akahane K, Araki T, Miura M. Resistance to Fas-mediated apoptosis activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene. 1998;275:1129.
67. Sah NK, Munshi A, Kurland JF, McDonnel TJ, Sul B, Meyn RE. Translation inhibitors sensitize prostate cancer cells to apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by activating c-Jun N-terminal kinase. J Biol Chem. 2003;278:20593-20602.
68. Yao H, Tang X, Shao X Feng L, Wu N, Yao K. Parthenolide protects human lens epithelial cells from oxidative stress-induced apoptosis via inhibition of activation of caspase-3 and caspase-9. Cell Res. 2007;17F:565-571.
69. Guzman ML, Rossi RM, Karnischky L, Li X, Peterson DR, Howard DS, Jordan CT. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood. 2005;105:4163-4169.